Umoja Biopharma
Pre-clinicalPioneering immunotherapy by reprogramming T cells in vivo to target cancer cells.
Founded
2019
Focus
Cell & Gene Therapy
About
Pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells.
Funding History
3Total raised: $267.3M
Series B$210MSoftBank Vision Fund 2Apr 15, 2023
Series A$53MMorningside VenturesMar 15, 2021
Seed$4.3MMorningside VenturesJan 15, 2020
Company Info
TypePrivate
Founded2019
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile